CRENESSITY

Growth

crinecerfont

NDAORALCAPSULEPriority Review

Approved

Dec 2024

Lifecycle

Growth

Competitive Pressure

0/100

Mechanism of Action

Corticotropin-releasing Factor Type 1 Receptor Antagonists

Pharmacologic Class:

Corticotropin-releasing Factor Type 1 Receptor Antagonist

Loss of Exclusivity

LOE Date

Jun 9, 2041

185 months away

Patent Expiry

Jun 9, 2041

Exclusivity Expiry

Dec 13, 2031

Patent Records (4)

Patent #	Expiry	Type	Use Code
10905690	Jan 21, 2035		U-4049
11311544	Jan 21, 2035		U-4049
11730739	Jan 21, 2035		U-4049
12128033	Jun 9, 2041	Substance	U-4049

External Resources

Full prescribing information

FDA approval history

Drug nomenclature & identifiers